Belief BioMed Collbaorates with Asklepios BioPharmaceutical for New gene Therapies
Thursday, September 26, 2024
Belief BioMed and AskBio have joined forces to advance potential gene therapies for diseases with significant unmet medical needs through a liver-targeted approach.
As part of the agreement, both companies will leverage their expertise in gene therapy technologies to explore innovative treatment options for liver-targeted diseases. This collaboration aims to enhance the core competitiveness of Belief BioMed in the gene therapy space, establishing a strong foundation for delivering more cutting-edge therapies to patients worldwide.
The strategic alliance with AskBio is built on shared vision, mutual trust, and complementary strengths and resources. This partnership, enables to accelerat the development of innovative treatments and making them accessible to patients globally.
Partnering with innovative, like-minded experts in gene therapy provides the opportunity to optimize our pipeline assets and strengthen the efforts to advance new therapies for conditions with critical unmet needs.
This novel and forward-thinking collaboration framework reflects the joint mission to address a broader spectrum of unmet medical needs.
Source: beliefbiomed.com
